Biotest AG (XTER:BIO3) Accumulated Depreciation : €0.0 Mil (As of Mar. 2025)

View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Biotest AG's quarterly accumulated depreciation increased from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€-420.0 Mil) but then stayed the same from Dec. 2024 (€-420.0 Mil) to Mar. 2025 (€0.0 Mil).

Biotest AG's annual accumulated depreciation increased from Dec. 2022 (€-352.8 Mil) to Dec. 2023 (€-384.0 Mil) and increased from Dec. 2023 (€-384.0 Mil) to Dec. 2024 (€-420.0 Mil).

Biotest AG Accumulated Depreciation Historical Data

The historical data trend for Biotest AG's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Accumulated Depreciation Chart

Biotest AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-295.40

-322.20

-352.80

-384.00

-420.00

Biotest AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-420.00	-

Biotest AG Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Biotest AG Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Biotest AG's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

BTTAY:USA BIO:Germany BIO3:Germany BIO:Germany BIO3:Germany BIO3:Germany BIO:Germany BIO3:Austria

Address

Landsteinerstrasse 5, PO Box 10 20 40, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.

Executives

Dr. Katrin Bernöster	Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke	Senior Vice President plasma alliances and proteine supply
Stephan Fleck	Vice President Corporate Controlling
Dr. Jörg Schüttrumpf	VP Corp. Research &Development
Michael Moritz	VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines